Masimo Q2 revenue $496.3M, GAAP EPS $0.29, non-GAAP $0.86; raises FY2024 guidance

MASIMO CORP

2024-Q2 EPS reported $0.64 revenue$989,100,000

Healthcare revenue $343.9M, non-healthcare $152.4M; GAAP operating income $28.3M, non-GAAP $72.9M.
GAAP net income $16.0M ($0.29/diluted share); non-GAAP net income $46.6M ($0.86/diluted share).
Raises FY2024 guidance: consolidated revenue $2,085-$2,135M, healthcare $1,385-$1,405M.
FY2024 non-GAAP EPS guidance raised to $3.80-$4.00; Q3 revenue guidance $495-$515M.
CEO cites record-breaking contracting, margin expansion, and innovation for strong results.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.